Company AFT Pharmaceuticals Limited

Equities

AFT

NZAFTE0001S4

Pharmaceuticals

End-of-day quote New Zealand S.E. 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
3.14 NZD +2.61% Intraday chart for AFT Pharmaceuticals Limited -3.09% -10.29%

Business Summary

AFT Pharmaceuticals Limited is a New Zealand-based multinational pharmaceutical company. The Company develops, markets and distributes a portfolio of pharmaceutical products across a range of therapeutic categories, which are distributed across three pharmaceutical distribution channels: over-the-counter (OTC), prescription and hospital. Its product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs. The Company develops and in-licenses products for sale by its own dedicated sales teams in Australia and New Zealand and in certain Southeast Asian markets, and out-licenses its products to local licensees and distributors in the rest of the world. A-Scabies, Allersoothe, Allersoothe Elixir, BecloClear, Bites, Calci-Tab, Candacort, Candacort Minipak, Candaderm, Coco-Scalp, Combolieve, Cromo-Fresh, Dry skin, Eczema, Emulsifying Ointment BP, Fenpaed, Fenpaed Double Strength, Ferro-Sachets, HYLO-FORTE and others.

Number of employees: 100

Sales per Business

NZD in Million2022Weight2023Weight Delta
Pharmaceutical Intellectual Property
100.0 %
130 100.0 % 157 100.0 % +20.20%

Sales per region

NZD in Million2022Weight2023Weight Delta
Australia
60.1 %
77 58.8 % 94 60.1 % +22.76%
New Zealand
28.1 %
35 26.9 % 44 28.1 % +25.53%
Rest of World
7.5 %
13 10.0 % 12 7.5 % -10.72%
Asia
4.4 %
5 4.2 % 7 4.4 % +24.18%

Managers

Managers TitleAgeSince
Founder - 97-09-03
Founder - 97-09-03
Director of Finance/CFO - 97-09-03
Chief Tech/Sci/R&D Officer - -
Corporate Officer/Principal - -
Sales & Marketing - 11-09-30
General Counsel - 06-01-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 20-12-22
Chairman - 15-06-21
Founder - 97-09-03
Founder - 97-09-03
Director/Board Member - 20-11-03
Director/Board Member - 23-09-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 104,866,260 26,770,886 ( 25.53 %) 0 25.53 %

Shareholders

NameEquities%Valuation
72,899,435 69.52 % 136 M $
Accident Compensation Corp.
4.630 %
4,855,056 4.630 % 9 M $
Apex Group Ltd.
2.766 %
2,900,650 2.766 % 5 M $
Guardians of New Zealand Superannuation
1.621 %
1,699,616 1.621 % 3 M $
Hama Holdings Ltd.
0.8276 %
867,826 0.8276 % 2 M $
Public Trust
0.4968 %
521,027 0.4968 % 975 472 $
Jon Lamb
0.2587 %
271,314 0.2587 % 507 957 $
203,333 0.1939 % 380 682 $
203,025 0.1936 % 380 105 $
178,764 0.1705 % 334 684 $

Company contact information

AFT Pharmaceuticals Ltd.

Nielsen House 129 Hurstmere Road, Takapuna

0622, Auckland

+

http://www.aftpharm.com
address AFT Pharmaceuticals Limited(AFT)

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
3.14 NZD
Average target price
3.7 NZD
Spread / Average Target
+17.83%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. AFT Stock
  4. Company AFT Pharmaceuticals Limited